跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
G-5
首页
药物
G-5
G-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of 8-arylamine-3H-imidazole [4, 5-g] quinazoline derivatives
申请人: UNIV ZHEJIANG
优先权: 2007
CN
STABLE APO ACTIVE FUSION OF A G PROTEIN COUPLED RECEPTOR (GPCR) AND A G PROTEIN ALPHA SUBUNIT HELIX 5
申请人: LILLY CO ELI
优先权: 2024
WO
G-protein-coupled receptor 5 (TGR5) modulators and methods of use thereof
申请人: INTERCEPT PHARMACEUTICALS INC
优先权: 2008
CN
2 件公开
7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
申请人: BAYER HEALTHCARE AG
优先权: 2002
US
Nitroguanosine-3 5-cyclic monophosphate compound and protein kinase G activating agent
申请人: UNIV KUMAMOTO
优先权: 2005
US
2 件公开
VEGETABLE OIL FOR PREPARING A COMPOSITION INHIBITING 5$G(A)- REDUCTASE ACTIVITY
申请人: EXPANSCIENCE LAB
优先权: 2001
EP
SELECTIVE G PROTEIN-COUPLED RECEPTOR KINASE 5 INHIBITORS, COMPOSITIONS, AND METHODS OF USE
申请人: PURDUE RESEARCH FOUNDATION
优先权: 2022
CN
EP
US
WO
4 件公开
SELECTIVE INHIBITORS OF G PROTEIN-COUPLED RECEPTOR KINASE 5, COMPOSITIONS, AND METHODS OF USE
申请人: PURDUE RESEARCH FOUNDATION
优先权: 2024
WO
药物
反馈